The current state of treatment for geographic atrophy is marked by two approved therapies that slow GA progression: ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

A pharmaceutical packaging business that changed ownership last fall plans to close a St. Louis-area plant this spring, ...

Samuel S Chowdhury, chairman of Square Pharmaceuticals, yesterday expressed his willingness to purchase 15 lakh shares of the company, valued at over Tk 32 crore at the current market price.

Square Pharmaceuticals – the country's leading drug manufacturer – has seen four of its directors collectively purchase 1.36 crore shares worth around Tk280 crore since 2020. The directors announced ...

A majority of 29 out of 55 Copenhagen City Council members voted to name a location "Palestine Square", it was announced on Thursday. The new name is set to take effect on April 1. The discussion ...

Jazz Pharmaceuticals (JAZZ) and Chimerix (CMRX) announced the companies have entered into a definitive agreement for Jazz to acquire Chimerix for $8.55 per share in cash, representing a total ...

March 5 (Reuters) - Merck's (MRK.N), opens new tab injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech Halozyme Therapeutics (HALO.O ...

LONDON, March 5 (Reuters) - "Cool heads" is the mantra of British Prime Minister Keir Starmer as he tries to heal a rapidly growing rift between the United States, Europe and Ukraine. Starmer, who ...

Square Pharmaceuticals Managing Director Tapan Chowdhury has announced plans to purchase 15 lakh shares of the company, worth over Tk32 crore, from the secondary or block market within the next 30 ...

(AP Photo/Frank Franklin II, File) NEW YORK (AP) — Big boxing in New York for long meant Madison Square Garden, in recent years Barclays Center as well. Fight night in Times Square promises to be a ...

Image: Sanjay Rawat India’s pharmaceutical sector is at a tipping point and over the next decade it could redefine operational strategies to tap the potential opportunities unlocking the next level of ...